COMPANY PROFILE

Prescient Surgical

Explore full profile

Prescient Surgical, Inc engages in the development of medical devices for the prevention of surgical site infection

San Carlos, United StatesFounded 2012Health Tech & Medtech

Valuation $50–100M Last recorded · 2018

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Prescient Surgical

Prescient Surgical is a medical device company specializing in advanced wound protection systems designed to reduce surgical site infections (SSIs). Operating in the healthcare market, Prescient Surgical serves hospitals and surgical centers, focusing on procedures with a high risk of infection, such as abdominal surgeries. The company's flagship product, CleanCision, integrates wound irrigation, protection, and suction into a single system. This system uses a microfluidic membrane connected to a surgeon-selected fluid source and suction to deliver continuous cleansing therapy, effectively removing contamination from surgical incisions. By doing so, CleanCision helps eliminate the root cause of infections, promoting optimal surgical outcomes. Prescient Surgical generates revenue through the sale of its CleanCision system to healthcare providers, leveraging its unique technology to address a critical need in infection control.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2012
Headquarters: San Carlos, United States
Employees: 1
Open positions: None listed
Dealroom signal: 56.3/100
Industry: Health
Sub-industry: Medical Devices
Sector: Health Tech & Medtech, Risk Management, Surgery, Infections and Infectious Diseases, Spinout, wound care, DT and LS, science-based
Technology: Deep Tech
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

6 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
GRANTOther financing	Feb 2021	$0	—	Undisclosed	↗
SERIES B✓Equity / VC	Nov 2018	$10M	$40M	Baxter Ventures · Summation Health Ventures · CWC HealthTech Advisors	↗

Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

Prescient Surgical website traffic

Latest recorded traffic for Prescient Surgical is 3.8K monthly website visits, up 192.3% over the last three months. Prescient Surgical's team grew 0% over the past year.

Latest monthly visits3.8K 3-month web change+192.3% 1-year team growth0%

Monthly website visitsOct 2017–Aug 2025

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
AMAmferiaNew medical devices with emphasis on antibacterial products	Mölndals kommun, Sweden	Operational	18	$8.9M	$18M
VEVerrixMedical device company developing solutions for rapid and accurate sterilization confirmation	San Clemente, United States	Acquired
CRCroivalveTreating Heart Valve Disease	Dublin, Ireland	Operational
ISInscope Medical SolutionsInscope Medical has developed an innovative technology that optimizes intubation, improving this high-risk procedure’s speed and safety	New Albany, United States	Operational
IBImbed BiosciencesAdvanced synthetic antimicrobial wound matrices that reduce infection, manage pain, and accelerate healing across chronic and acute wounds.	Madison, United States	Operational
COCorindusCorindus develops and commercializes remote robotic systems for interventional procedures	Natick, United States	Acquired
CMCheetah MedicalCheetah Medical is a device company developing non-invasive cardiac output and hemodynamic monitoring devices	Tel Aviv-Yafo, Israel	Acquired
XEXeltisRestorative cardiovascular devices enabling natural tissue regeneration.	Eindhoven, Netherlands	Operational